FindTrial
Sign In

Clinical study of regional corneal endothelial injury following the combination of phacoemulsification, intraocular lens implantation and vitrectomy

Clinical study of regional corneal endothelial injury following the combination of phacoemulsification, intraocular lens implantation and vitrectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058663
Enrollment
Unknown
Registered
2022-04-13
Start date
2022-04-02
Completion date
Unknown
Last updated
2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitreoretinal disease combined with cataract

Interventions

Combination of phacoemulsification, intraocular lens implantation and vitrectomy:Combination of phacoemulsification, intraocular lens implantation and vitrectomy

Sponsors

Tongji Hospital of Tongji University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Vitreoretinal diseases requiring vitrectomy; 2. Cataract with grade II or above according to LOCS III.

Exclusion criteria

Exclusion criteria: 1. Patients with severe dry eye, keratopathy, ocular trauma and ocular surgery history; 2. Unable to cooperate with the inspection or complete the follow-up.

Design outcomes

Primary

MeasureTime frame
Corneal densitometry;—

Secondary

MeasureTime frame
Corneal endotheliam cell dendity;Corneal thickness;Corneal endothelial cell loss rate;Corneal endothelial cells hexagonal ratio;Visual acuity;Slit-lamp examination;—

Countries

China

Contacts

Public ContactBi Yanlong

Tongji Hospital of Tongji University

biyanlong@tongji.edu.cn+86 13816261568

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026